Status:
ACTIVE_NOT_RECRUITING
Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)
Lead Sponsor:
Sanofi
Conditions:
Dermatitis Atopic
Eligibility:
All Genders
Up to 11 years
Brief Summary
Primary Objective: To explore associations between biomarkers of atopic dermatitis (AD) and: * Disease state and time course of AD, * Disease state and evolution of selected atopic comorbid conditio...
Detailed Description
The estimated enrollment duration is approximately 2 years, while duration of observation is approximately 5 years.
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Participation in the OBS15333 pediatric atopic dermatitis (AD) registry.
- Signed informed consent by the parent/legally acceptable representative and assent by the participant appropriate to the participant's age.
- Exclusion criteria:
- Not applicable.
- The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Exclusion
Key Trial Info
Start Date :
April 5 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2026
Estimated Enrollment :
266 Patients enrolled
Trial Details
Trial ID
NCT03849716
Start Date
April 5 2019
End Date
September 30 2026
Last Update
July 11 2025
Active Locations (48)
Enter a location and click search to find clinical trials sorted by distance.
1
C Squared Research Center Site Number : 8400068
Birmingham, Alabama, United States, 35209
2
Cahaba Dermatology Site Number : 8400046
Birmingham, Alabama, United States, 35244
3
C2 Research Center, LLC Site Number : 8400071
Montgomery, Alabama, United States, 36117
4
Axis Clinical Trials Site Number : 8400025
Los Angeles, California, United States, 90036